Solid Bio hit as FDA slaps clinical hold on DMD gene therapyThe FDA has placed another clinical hold on a gene therapy for Duchenne muscular dystrophy developed by Solid Share XSolid Bio hit as FDA slaps clinical hold on DMD gene therapyhttps://pharmaphorum.com/news/solid-bio-hit-as-fda-slaps-clinical-hold-on-dmd-gene-therapy/
Gene therapy biotech shares sink on inconclusive trial resultsShares in two US gene therapy biotechs have fallen after two cutting-edge treatments failed to produce convincing results Share XGene therapy biotech shares sink on inconclusive trial resultshttps://pharmaphorum.com/news/gene-therapy-biotech-shares-sink-on-inconclusive-trial-results/